Lonza almost triples Schuldschein to €870m-equivalent
Lonza, the Swiss pharmaceutical ingredients and dosing methods supplier, has closed an €870m-equivalent dual tranche Schuldschein loan, refinancing debt backing its acquisition of US drug capsules maker Capsugel.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: